51
Views
3
CrossRef citations to date
0
Altmetric
Editorial

Aortic and mitral valve replacement in children: current options and outcomes

Pages 805-809 | Published online: 10 Jan 2014

References

  • Alsoufi B, Al-Halees Z, Manlhiot C et al. Mechanical valves versus the Ross procedure for aortic valve replacement in children: propensity-adjusted comparison of long-term outcomes. J. Thorac. Cardiovasc. Surg.137, 362–370 (2009).
  • Karamlou T, Jang K, Williams WG et al. Outcomes and associated risk factors for aortic valve replacement in 160 children: a competing-risks analysis. Circulation112, 3462–3469 (2005).
  • Alsoufi B, Manlhiot C, Al-Ahmadi M et al. Outcomes and associated risk factors for mitral valve replacement in children. Eur. J. Cardiothorac. Surg. DOI: 10.1016/j.ejcts.2010.12.060 (2011) (Epub ahead of print).
  • Alsoufi B, Karamlou T, Bradley T et al. Short and midterm results of aortic valve cusp extension in the treatment of children with congenital aortic valve disease. Ann. Thorac. Surg.82, 1292–1299 (2006).
  • Polimenakos AC, Sathanandam S, Elzein C, Barth MJ, Higgins RS, Ilbawi MN. Aortic cusp extension valvuloplasty with or without tricuspidization in children and adolescents: long-term results and freedom from aortic valve replacement. J. Thorac. Cardiovasc. Surg.139, 933–941 (2010).
  • Oppido G, Davies B, McMullan DM et al. Surgical treatment of congenital mitral valve disease: mid- term results of a repair-oriented policy. J. Thorac. Cardiovasc. Surg.135, 1313–1329 (2008).
  • Alsoufi B, Manlhiot C, McCrindle BW et al. Results after mitral valve replacement with mechanical prostheses in young children. J. Thorac. Cardiovasc. Surg.139, 1189–1196 (2010).
  • Alsoufi B, Al-Halees Z, Manlhiot C et al. Superior results following the Ross procedure in patients with congenital heart disease. J. Heart Valve Dis.19, 269–277 (2010).
  • Hickey EJ, Yeh T Jr, Jacobs JP et al. Ross and Yasui operations for complex biventricular repair in infants with critical left ventricular outflow tract obstruction. Eur. J. Cardiothorac. Surg.37, 279–288 (2010).
  • Alsoufi B, Al-Halees Z, Manlhiot C et al. Intermediate results following complex biventricular repair of left ventricular outflow tract obstruction in neonates and infants. Eur. J. Cardiothorac. Surg.38, 431–438 (2010).
  • Alsoufi B, Manlhiot C, Fadel B et al. The Ross procedure in children: preoperative haemodynamic manifestation has significant effect on late autograft re-operation. Eur. J. Cardiothorac. Surg.38, 547–555 (2010).
  • Khwaja S, Nigro JJ, Starnes VA. The Ross procedure is an ideal aortic valve replacement operation for the teen patient. Semin. Thorac. Cardiovasc. Surg. Pediatr. Cardiol. Surg. Annu.173–175 (2005).
  • Kadner A, Raisky O, Degandt A et al. The Ross procedure in infants and young children. Ann. Thorac. Surg.85, 803–808 (2008).
  • Pasquali SK, Shera D, Wernovsky G et al. Midterm outcomes and predictors of reintervention after the Ross procedure in infants, children, and young adults. J. Thorac. Cardiovasc. Surg.133, 893–899 (2007).
  • Laudito A, Brook MM, Suleman S et al. The Ross procedure in children and young adults: a word of caution. J. Thorac. Cardiovasc. Surg.122, 147–153 (2001).
  • David TE, Omran A, Ivanov J et al. Dilation of the pulmonary autograft after the Ross procedure. J. Thorac. Cardiovasc. Surg.119, 210–220 (2000).
  • Slater M, Shen I, Welke K, Komanapalli C, Ungerleider R. Modification to the Ross procedure to prevent autograft dilatation. Semin. Thorac. Cardiovasc. Surg. Pediatr. Cardiol. Surg. Annu.181–184 (2005).
  • Ishizaka T, Devaney EJ, Ramsburgh SR, Suzuki T, Ohye RG, Bove EL. Valve sparing aortic root replacement for dilatation of the pulmonary autograft and aortic regurgitation after the Ross procedure. Ann. Thorac. Surg.75, 1518–1522 (2003).
  • Nordmeyer J, Coats L, Bonhoeffer P. Current experience with percutaneous pulmonary valve implantation. Semin. Thorac. Cardiovasc. Surg.18, 122–125 (2006).
  • Alsoufi B, Manlhiot C, McCrindle BW et al. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes? Eur. J. Cardiol. Othorac. Surg.36, 84–90 (2009).
  • Rafii DY, Davies RR, Carroll SJ, Quaegebeur JM, Chen JM. Age less than two years is not a risk factor for mortality after mitral valve replacement in children. Ann. Thorac. Surg.91, 1228–1234 (2011).
  • Caldarone CA, Raghuveer G, Hills CB et al. Long-term survival after mitral valve replacement in children aged <5 years: a multi-institutional study. Circulation104(Suppl. 1), I143–I147 (2001).
  • Kojori F, Chen R, Caldarone CA et al. Outcomes of mitral valve replacement in children: a competing-risks analysis. J. Thorac. Cardiovasc. Surg.128, 703–709 (2004).
  • Kabbani S, Jamil H, Nabhani F et al. Analysis of 92 mitral pulmonary autograft replacement (Ross II) operations. J. Thorac. Cardiovasc. Surg.134, 902–908 (2007).
  • Alsoufi B, Al-Halees Z, Fadel B et al. Simultaneous aortic and mitral valve replacement in children: time-related outcomes and risk factors. J. Heart Valve Dis.19, 341–348 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.